ERs may be key to getting HIV prevention meds to those who need them
NCT ID NCT04429971
First seen Jan 11, 2026 · Last updated Jun 13, 2026 · Updated 23 times
Summary
This study tested a new way to offer HIV prevention medication (PrEP) to people at high risk right in the emergency department. 26 adults who were HIV-negative and medically stable took part. The goal was to see if starting PrEP in the ER helps them follow up with a doctor within 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai Beth Israel Hospital
New York, New York, 10003, United States
Conditions
Explore the condition pages connected to this study.